The company may acquire Intas pharma for Rs. 15,000 crore (US$ 2.3 billion). Sun is reportedly in early talks with Intas regarding the deal.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
The company may acquire Intas pharma for Rs. 15,000 crore (US$ 2.3 billion). Sun is reportedly in early talks with Intas regarding the deal.
| Subscribe To Our Free Newsletter |
